MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jot.2023.09.007

Медицинская библиотека · Journal of orthopaedic translation · 2023

Muscle-bone crosstalk via endocrine signals and potential targets for osteosarcopenia-related fracture.

Sheng Renwang, Cao Mumin, Song Mingyuan, Wang Mingyue, Zhang Yuanwei, Shi Liu, Xie Tian, Li Yingjuan, Wang Jinyu, Rui Yunfeng

СтатьяОбзорПеревод в очереди

Аннотация

BACKGROUND

Osteosarcopenia is a syndrome coexisting sarcopenia and osteopenia/osteoporosis, with a high fracture risk. Recently, skeletal muscle and bone have been recognized as endocrine organs capable of communication through secreting myokines and osteokines, respectively. With a deeper understanding of the muscle-bone crosstalk, these endocrine signals exhibit an important role in osteosarcopenia development and fracture healing.

METHODS

This review summarizes the role of myokines and osteokines in the development and treatment of osteosarcopenia and fracture, and discusses their potential for osteosarcopenia-related fracture treatment.

RESULTS

Several well-defined myokines (myostatin and irisin) and osteokines (RANKL and SOST) are found to not only regulate skeletal muscle and bone metabolism but also influence fracture healing processes. Systemic interventions targeting these biochemical signals has shown promising results in improving the mass and functions of skeletal muscle and bone, as well as accelerating fracture healing processes.

CONCLUSION

The regulation of muscle-bone crosstalk via biochemical signals presents a novel and promising strategy for treating osteosarcopenia and fracture by simultaneously enhancing bone and muscle anabolism. We propose that myostatin, irisin, RANKL, and SOST may serve as potential targets to treat fracture patients with osteosarcopenia.

THE TRANSLATIONAL POTENTIAL OF THIS ARTICLE: Osteosarcopenia is an emerging geriatric syndrome where sarcopenia and osteoporosis coexist, with high fracture risk, delayed fracture healing, and increased mortality. However, no pharmacological agent is available to treat fracture patients with osteosarcopenia. This review summarizes the role of several myokines and osteokines in the development and treatment of osteosacropenia and fracture, as well as discusses their potential as intervention targets for osteosarcopenia-related fracture, which provides a novel and promising strategy for future osteosarcopenia-related fracture treatment.

Для цитирования: Sheng Renwang, Cao Mumin, Song Mingyuan, Wang Mingyue, Zhang Yuanwei, Shi Liu, Xie Tian, Li Yingjuan, Wang Jinyu, Rui Yunfeng. Muscle-bone crosstalk via endocrine signals and potential targets for osteosarcopenia-related fracture.. Journal of orthopaedic translation. 2023. DOI: 10.1016/j.jot.2023.09.007.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.